Lipid-lowering treatment for homozygous familial hypercholesterolaemia – Authors' reply
Authors:
- Marina CuchelMCMarina Cuchel
- Daniel J RaderDRDaniel J Rader
- 1 April 2013
- journal article
- Published by Elsevier in The Lancet
- Vol. 381 (9873) , 1183
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 studyThe Lancet, 2013
- Dissociation Between Intrahepatic Triglyceride Content and Insulin Resistance in Familial HypobetalipoproteinemiaGastroenterology, 2010
- Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemiaNature Clinical Practice Cardiovascular Medicine, 2008
- Preserved direct hepatic insulin action in rats with diet-induced hepatic steatosisAmerican Journal of Physiology-Endocrinology and Metabolism, 2004